BR9911422A - Processo de tratamento de hipertensão pulmonar - Google Patents

Processo de tratamento de hipertensão pulmonar

Info

Publication number
BR9911422A
BR9911422A BR9911422-4A BR9911422A BR9911422A BR 9911422 A BR9911422 A BR 9911422A BR 9911422 A BR9911422 A BR 9911422A BR 9911422 A BR9911422 A BR 9911422A
Authority
BR
Brazil
Prior art keywords
pulmonary hypertension
treatment process
hypertension treatment
treatment
levosimendan
Prior art date
Application number
BR9911422-4A
Other languages
English (en)
Inventor
Lasse Lehtonen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of BR9911422A publication Critical patent/BR9911422A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

"PROCESSO DE TRATAMENTO DE HIPERTENSãO PULMONAR" Levosimendan, ou (-) - [ [4- (1,4,5,6-tetraidro-4-metil-6-oxo-3-piridazinil) fenil] hidrazono] propano dinitrila, que foi anteriormente sugerido para o tratamento de insuficiência cardíaca congestiva é útil no tratamento de hipertensão pulmonar.
BR9911422-4A 1998-06-25 1999-06-18 Processo de tratamento de hipertensão pulmonar BR9911422A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981473A FI981473A (fi) 1998-06-25 1998-06-25 Menetelmä pulmonaalihypertension hoitamiseksi
PCT/FI1999/000540 WO1999066912A2 (en) 1998-06-25 1999-06-18 Method of treating pulmonary hypertension

Publications (1)

Publication Number Publication Date
BR9911422A true BR9911422A (pt) 2001-03-13

Family

ID=8552079

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911422-4A BR9911422A (pt) 1998-06-25 1999-06-18 Processo de tratamento de hipertensão pulmonar

Country Status (24)

Country Link
US (1) US6462045B1 (pt)
EP (1) EP1089737B1 (pt)
JP (1) JP4536922B2 (pt)
KR (1) KR100661769B1 (pt)
AT (1) ATE226076T1 (pt)
AU (1) AU748883B2 (pt)
BR (1) BR9911422A (pt)
CA (1) CA2335280C (pt)
CZ (1) CZ300844B6 (pt)
DE (1) DE69903546T2 (pt)
DK (1) DK1089737T3 (pt)
EA (1) EA003055B1 (pt)
EE (1) EE04355B1 (pt)
ES (1) ES2186375T3 (pt)
FI (1) FI981473A (pt)
HU (1) HU226021B1 (pt)
MX (1) MXPA00012618A (pt)
NO (1) NO317593B1 (pt)
NZ (1) NZ508833A (pt)
PL (1) PL193055B1 (pt)
PT (1) PT1089737E (pt)
SK (1) SK284581B6 (pt)
WO (1) WO1999066912A2 (pt)
ZA (1) ZA200007462B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20001542A (fi) * 2000-06-29 2001-12-30 Orion Yhtymae Oyj Menetelmä septisen sokin hoitamiseksi
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
FI20010233A0 (fi) 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20040675A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä sydämen hypertrofian hoitoon ja estoon
WO2006087420A2 (en) * 2005-02-18 2006-08-24 Orion Corporation A method for treating heart failure
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302595B1 (en) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil for treatment of pulmonary hypertension or right heart failure
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
RO113612B1 (ro) * 1991-04-17 1998-09-30 Merck & Co Inc Compozitie oftalmica
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
EE200000775A (et) 2002-04-15
NO317593B1 (no) 2004-11-15
JP2002518436A (ja) 2002-06-25
DE69903546T2 (de) 2003-06-18
EA003055B1 (ru) 2002-12-26
AU748883B2 (en) 2002-06-13
ZA200007462B (en) 2002-03-13
CA2335280A1 (en) 1999-12-29
KR20010072640A (ko) 2001-07-31
SK284581B6 (sk) 2005-07-01
DE69903546D1 (de) 2002-11-21
HUP0102929A2 (hu) 2002-04-29
HU226021B1 (en) 2008-03-28
FI981473A (fi) 1999-12-26
DK1089737T3 (da) 2003-02-10
NO20006652D0 (no) 2000-12-22
MXPA00012618A (es) 2005-06-06
FI981473A0 (fi) 1998-06-25
PL193055B1 (pl) 2007-01-31
EE04355B1 (et) 2004-10-15
NZ508833A (en) 2002-10-25
PL345467A1 (en) 2001-12-17
US6462045B1 (en) 2002-10-08
ATE226076T1 (de) 2002-11-15
CA2335280C (en) 2007-10-30
SK19252000A3 (sk) 2002-04-04
HUP0102929A3 (en) 2002-07-29
ES2186375T3 (es) 2003-05-01
EA200100074A1 (ru) 2001-06-25
JP4536922B2 (ja) 2010-09-01
NO20006652L (no) 2000-12-22
EP1089737B1 (en) 2002-10-16
KR100661769B1 (ko) 2006-12-28
EP1089737A2 (en) 2001-04-11
AU4786499A (en) 2000-01-10
CZ20004663A3 (en) 2001-05-16
WO1999066912A2 (en) 1999-12-29
PT1089737E (pt) 2003-03-31
WO1999066912A3 (en) 2000-03-16
CZ300844B6 (cs) 2009-08-26

Similar Documents

Publication Publication Date Title
BR9806752A (pt) Ftalazinonas.
ATE336248T1 (de) Verwendung von thiazolidinderivaten als antihyperglykämische mittel
ATE212847T1 (de) Verwendung von phenol substituierten diphosphonaten als antineoplastische substanten
BR9510420A (pt) Azetidin-2-onas substituìdas para o tratamento de aterosclerose
BR9911422A (pt) Processo de tratamento de hipertensão pulmonar
BR9909869A (pt) Composições perorais de liberação controlada de levosimendan
NO20006026D0 (no) Fremgangsmåter og sammensetninger som er nyttige for modulering av angiogenese ved å bruke tyrosinkinase SRC
BR0012072A (pt) Processo para o tratamento ou prevenção de vasoespasmo de enxerto coronário
NO952427D0 (no) Metode for behandling av kronisk prostatitt med 17 substituerte karbamoyl-4-aza-5
BR9713346A (pt) Inibidores de indenos de cox - 2
FI20001542A (fi) Menetelmä septisen sokin hoitamiseksi
DE60016038D1 (de) Neue verwendung von levosimendan
DE60111044D1 (de) Verwendung von aminen
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
NO983418D0 (no) FremgangsmÕte ved behandling av f¶r, samt f¶rprodukter
GB9707643D0 (en) 2-(3,5-Difluorophenyl)-3-(4-(methylsulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cox-2

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/50, A61P 9/00

Ipc: A61K 31/50 (2007.10), A61P 9/00 (2007.10)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]